Clinical Trials
7
Active:0
Completed:6
Trial Phases
1 Phases
Phase 1:7
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 1
7 (100.0%)COMPOUND (INN): HOE490O - GLIMEPIRIDE / METFORMIN HCl (Amaryl® M)0 (Glimepiride/Metformin Hydrochloride Immediate Release Combination Tablet) in Fed Conditions in Healthy Male and/or Female Subjects.
Phase 1
Withdrawn
- Conditions
- Healthy
- First Posted Date
- 2015-03-23
- Last Posted Date
- 2020-09-18
- Lead Sponsor
- Pharmaceutical Research Unit, Jordan
- Registration Number
- NCT02395237
- Locations
- 🇯🇴
Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit, Amman, Jordan
Semi-replicate Crossover Bioequivalence Study of Dirithromycin of (Abdi İbrahim İlaç San. Ve Tic. A. Ş., Turkey) in Healthy Subjects Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: DYNABAC 250 MG ENTERIC COATED TABLET
- First Posted Date
- 2014-09-11
- Last Posted Date
- 2020-09-18
- Lead Sponsor
- Pharmaceutical Research Unit, Jordan
- Target Recruit Count
- 48
- Registration Number
- NCT02237768
- Locations
- 🇯🇴
Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit, Amman, Jordan
Semi-replicate Crossover Bioequivalence Study of Dirithromycin in Healthy Subjects Under Fed Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: DYNABAC 250 MG ENTERIC COATED TABLET
- First Posted Date
- 2014-09-11
- Last Posted Date
- 2020-09-18
- Lead Sponsor
- Pharmaceutical Research Unit, Jordan
- Target Recruit Count
- 48
- Registration Number
- NCT02237807
- Locations
- 🇯🇴
Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit, Amman, Jordan
Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fasting Condition
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: DYNABAC 250 MG ENTERIC COATED TABLET
- First Posted Date
- 2014-07-10
- Last Posted Date
- 2014-07-10
- Lead Sponsor
- Pharmaceutical Research Unit, Jordan
- Target Recruit Count
- 12
- Registration Number
- NCT02185833
- Locations
- 🇯🇴
Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit, Amman, Jordan
Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fed Condition
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: DYNABAC 250 MG ENTERIC COATED TABLET
- First Posted Date
- 2014-07-10
- Last Posted Date
- 2014-07-10
- Lead Sponsor
- Pharmaceutical Research Unit, Jordan
- Target Recruit Count
- 12
- Registration Number
- NCT02185846
- Locations
- 🇯🇴
Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit, Amman, Jordan
- Prev
- 1
- 2
- Next
News
No news found